You are here

clinical trials

Vertex Presents Positive, Updated VX-880 Results From Ongoing Phase 1/2 Study in Type 1 Diabetes at the European Association for the Study of Diabetes 59th Annual Meeting

Vertex Presents Positive, Updated VX-880 Results From Ongoing Phase 1/2 Study in Type 1 Diabetes at the European Association for the Study of Diabetes 59th Annual Meeting

Businesswire

Vertex Pharmaceuticals

clinical trials

type 1 diabetes

Flag link:

Takeda to Withdraw Oncology Drug Exkivity from U.S. Market

Takeda to Withdraw Oncology Drug Exkivity from U.S. Market

Managed Healthcare Executive

clinical trials

non-small cell lung cancer

Flag link:

BPGbio to accelerate pancreatic cancer drug after ‘promising’ initial trials

BPGbio to accelerate pancreatic cancer drug after ‘promising’ initial trials

Biopharma Reporter

artificial intelligence

pancreatic cancer

clinical trials

Flag link:

Henlius and OncoHost partner to predict trial outcomes using machine learning

Henlius and OncoHost partner to predict trial outcomes using machine learning

Clinical Trials Arena

clinical trials

machine learning

artificial intelligence

Flag link:

Syndax stops pivotal cancer trial early for efficacy but details disappoint, sending stock down

Syndax stops pivotal cancer trial early for efficacy but details disappoint, sending stock down

Fierce Biotech

Syndax Pharmaceuticals

clinical trials

Flag link:

Novartis eyes accelerated FDA approval for iptacopan across multiple indications

Novartis eyes accelerated FDA approval for iptacopan across multiple indications

Clinical Trials Arena

clinical trials

IgA nephropathy

Flag link:

AbbVie’s venetoclax fails Phase III myeloma trial

AbbVie’s venetoclax fails Phase III myeloma trial

Clinical Trials Arena

Multiple Myeloma

clinical trials

Flag link:

FDA Launches Pilot Program to Help Further Accelerate Development of Rare Disease Therapies

FDA Launches Pilot Program to Help Further Accelerate Development of Rare Disease Therapies

Applied Clinical Trials Online

clinical trials

drug development

Flag link:

Regeneron’s linvoseltamab shows early and durable response in pre-treated MM

Regeneron’s linvoseltamab shows early and durable response in pre-treated MM

Clinical Trials Arena

clinical trials

bispecific antibodies

Flag link:

Structure Therapeutics surges on promising early stage obesity drug data

Structure Therapeutics surges on promising early stage obesity drug data

Reuters

Structure Therapeutics

clinical trials

Flag link:

Bionomics’ PTSD Candidate Clears Phase IIb Study, Stock Jumps 415%

Bionomics’ PTSD Candidate Clears Phase IIb Study, Stock Jumps 415%

BioSpace

clinical trials

Flag link:

Aleta aims for pivotal US trial with CAR T-cell engager

Aleta aims for pivotal US trial with CAR T-cell engager

Clinical Trials Arena

Aleta Biotherapeutics

clinical trials

Flag link:

Patient Death Likely from Virus Used to Deliver Gene-Editing Therapy: NEJM Study

Patient Death Likely from Virus Used to Deliver Gene-Editing Therapy: NEJM Study

BioSpace

clinical trials

Duchenne Muscular Dystrophy

Flag link:

Gilead Axes Phase III Magrolimab Trial Based on Disappointing Data

Gilead Axes Phase III Magrolimab Trial Based on Disappointing Data

BioSpace

Gilead Sciences

clinical trials

Flag link:

Cardiff Oncology Announces Positive Clinical Data in Pancreatic Cancer and Small Cell Lung Cancer, including Single-Agent Activity from Onvansertib Monotherapy

Cardiff Oncology Announces Positive Clinical Data in Pancreatic Cancer and Small Cell Lung Cancer, including Single-Agent Activity from Onvansertib Monotherapy

BioSpace

Cardiff Oncology

pancreatic cancer

clinical trials

Flag link:

Immunovant shares surge as early antibody treatment data beats expectations

Immunovant shares surge as early antibody treatment data beats expectations

Yahoo/Reuters

clinical trials

autoimmune diseases

Flag link:

Ionis' lipid-lowering drug hits phase 3 goal, raising hopes in untapped rare disease market

Ionis' lipid-lowering drug hits phase 3 goal, raising hopes in untapped rare disease market

Fierce Biotech

Ionis Pharmaceuticals

clinical trials

familial chylomicronemia syndrome

Flag link:

Elderly exclusion: Clinical trials still fall short enrolling older adults

Elderly exclusion: Clinical trials still fall short enrolling older adults

Pharma Voice

clinical trials

Flag link:

Daiichi Sankyo reports positive results from trial of breast cancer therapy

Daiichi Sankyo reports positive results from trial of breast cancer therapy

Clinical Trials Arena

clinical trials

Flag link:

Novartis eyes first-line use of Lutathera after trial win

Novartis eyes first-line use of Lutathera after trial win

Pharmaphorum

clinical trials

neuroendocrine tumors

Flag link:

Pages